VCWA
ACIU icon

Vanguard Capital Wealth Advisors’s AC Immune ACIU Stock Holding History

Vanguard Capital Wealth Advisors’s Portfolio ACIU Stock Details ACIU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-14,000
Closed -$55.9K – 118
2024
Q2 		$55.9K Buy
+14,000
New +$46.3K 0.04% 137

Other funds holding ACIU

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Vanguard Capital Wealth Advisors's ACIU Position: Q3 2024 in Review

Vanguard Capital Wealth Advisors sold out of AC Immune (ACIU) in Q3 2024, closing a stake of 14,000 shares — an estimated $55.9K sold.

Vanguard Capital Wealth Advisors first reported a position in ACIU in Q2 2024 and held it in 1 quarter. The position peaked at $55.9K in Q2 2024. 43 funds tracked by Wall St. Rank hold ACIU as of Q3 2024.

  • Vanguard Capital Wealth Advisors reported no remaining AC Immune position as of Q3 2024 after selling out during the quarter.
  • Vanguard Capital Wealth Advisors sold 14,000 AC Immune shares in Q3 2024, an estimated $55.9K.
  • Vanguard Capital Wealth Advisors first reported a position in AC Immune in Q2 2024 and held it in 1 quarter.
  • Vanguard Capital Wealth Advisors's AC Immune position peaked at $55.9K in Q2 2024.
  • 43 funds tracked by Wall St. Rank held AC Immune as of Q3 2024.

Based on Vanguard Capital Wealth Advisors's 13F filing for Q3 2024, filed 25 Oct 2024.